Future Universal Vaccine A Key Part Of White House COVID-19 Strategy

The Biden administration wants to accelerate research and development of a universal SARS-CoV-2 vaccine that protects against COVID-19 and all its variants, and officials plan to ask Congress to provide additional funding to support development efforts, the White House says in its national COVID-19 response strategy released Wednesday (March 2). It’s unclear how much money the administration would like from Congress. White House COVID-19 Response Coordinator Jeff Zients said the administration will work with lawmakers in the coming weeks to...
Article Type: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 03/04/2022
FDA Volume: 
Vol. 28, No. 9
Author: 








WH Plan To Tackle COVID Hinges On Quick Reviews, Small Trials, Funding

The Biden administration is calling for Congress to provide funding to support streamlined FDA review and development of future COVID-19 vaccines and therapies, including variant-specific products that can be quickly developed, authorized and deployed should they be needed in the future. The funding request is part of the administration’s wide-ranging strategy to tackle COVID-19 going forward, which was laid out in a 96-page report released Wednesday (March 2) . White House COVID-19 Response Coordinator Jeff Zients said the administration will...
Article Type: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 03/04/2022
FDA Volume: 
Vol. 28, No. 9
Author: 




Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.